NASDAQ:ALDX
$6.18
(
-0.323%
)
Friday, 3rd Feb 2023
Aldeyra Therapeutics Stock Price (Quote)
Range | Low Price | High Price | Comment |
---|---|---|---|
30 days | $5.75 | $7.19 | Friday, 3rd Feb 2023 ALDX stock ended at $6.18. This is 0.323% less than the trading day before Thursday, 2nd Feb 2023. During the day the stock fluctuated 2.46% from a day low at $6.09 to a day high of $6.24. |
90 days | $4.96 | $7.19 | |
52 weeks | $2.36 | $7.99 |
Historical Aldeyra Therapeutics prices
Date | Open | High | Low | Close | Volume |
2023-02-03 | $6.12 | $6.24 | $6.09 | $6.18 | 265 867 |
2023-02-02 | $6.10 | $6.21 | $6.05 | $6.20 | 276 965 |
2023-02-01 | $5.97 | $6.14 | $5.88 | $6.07 | 260 954 |
2023-01-31 | $5.86 | $6.03 | $5.84 | $5.90 | 273 251 |
2023-01-30 | $6.04 | $6.09 | $5.75 | $5.77 | 347 107 |
2023-01-27 | $5.93 | $6.26 | $5.93 | $6.09 | 363 551 |
2023-01-26 | $6.08 | $6.17 | $6.01 | $6.08 | 260 959 |
2023-01-25 | $6.01 | $6.14 | $5.90 | $6.08 | 281 514 |
2023-01-24 | $6.07 | $6.18 | $5.94 | $6.06 | 285 779 |
2023-01-23 | $6.28 | $6.32 | $6.07 | $6.11 | 257 525 |
2023-01-20 | $6.19 | $6.36 | $6.08 | $6.32 | 254 200 |
2023-01-19 | $6.03 | $6.16 | $5.97 | $6.10 | 315 525 |
2023-01-18 | $6.25 | $6.37 | $6.05 | $6.07 | 380 500 |
2023-01-17 | $6.41 | $6.52 | $6.24 | $6.25 | 282 380 |
2023-01-13 | $6.70 | $6.90 | $6.42 | $6.45 | 336 839 |
2023-01-12 | $6.41 | $6.80 | $6.28 | $6.77 | 239 200 |
2023-01-11 | $6.42 | $6.44 | $6.16 | $6.31 | 259 300 |
2023-01-10 | $6.36 | $6.52 | $6.19 | $6.44 | 469 729 |
2023-01-09 | $7.02 | $7.10 | $6.26 | $6.37 | 533 829 |
2023-01-06 | $6.99 | $7.19 | $6.75 | $6.98 | 651 100 |
2023-01-05 | $6.79 | $7.07 | $6.78 | $7.04 | 249 726 |
2023-01-04 | $7.06 | $7.14 | $6.82 | $6.91 | 435 561 |
2023-01-03 | $7.01 | $7.08 | $6.78 | $6.96 | 398 078 |
2022-12-30 | $7.06 | $7.06 | $6.72 | $6.96 | 271 168 |
2022-12-29 | $6.69 | $7.15 | $6.64 | $7.09 | 444 127 |
2022-12-28 | $6.59 | $6.75 | $6.43 | $6.62 | 235 025 |
2022-12-27 | $6.69 | $6.76 | $6.43 | $6.61 | 476 017 |
2022-12-23 | $6.48 | $6.62 | $6.38 | $6.60 | 278 768 |
2022-12-22 | $6.46 | $6.51 | $6.16 | $6.49 | 461 498 |
2022-12-21 | $6.15 | $6.58 | $5.95 | $6.48 | 721 285 |
2022-12-20 | $6.07 | $6.25 | $6.07 | $6.10 | 137 094 |
2022-12-19 | $6.38 | $6.40 | $5.96 | $6.08 | 299 468 |
2022-12-16 | $6.21 | $6.37 | $6.17 | $6.32 | 309 256 |
2022-12-15 | $6.10 | $6.25 | $6.03 | $6.22 | 233 256 |
2022-12-14 | $6.32 | $6.36 | $6.03 | $6.20 | 342 666 |
2022-12-13 | $6.41 | $6.41 | $6.17 | $6.34 | 253 944 |
2022-12-12 | $6.19 | $6.29 | $5.79 | $6.22 | 434 036 |
2022-12-09 | $6.06 | $6.21 | $5.96 | $6.14 | 256 665 |
2022-12-08 | $6.15 | $6.15 | $5.89 | $6.08 | 288 509 |
2022-12-07 | $6.16 | $6.19 | $5.91 | $6.04 | 368 478 |
2022-12-06 | $6.41 | $6.54 | $6.10 | $6.20 | 528 268 |
2022-12-05 | $6.52 | $6.52 | $6.25 | $6.46 | 372 897 |
2022-12-02 | $6.09 | $6.56 | $5.99 | $6.52 | 519 170 |
2022-12-01 | $5.65 | $6.19 | $5.63 | $6.16 | 924 761 |
2022-11-30 | $5.50 | $5.67 | $5.37 | $5.60 | 467 146 |
2022-11-29 | $5.18 | $5.50 | $5.18 | $5.46 | 287 836 |
2022-11-28 | $5.39 | $5.61 | $5.16 | $5.20 | 202 300 |
2022-11-25 | $5.31 | $5.57 | $5.26 | $5.46 | 153 987 |
2022-11-23 | $5.31 | $5.50 | $5.11 | $5.38 | 414 841 |
2022-11-22 | $5.20 | $5.32 | $4.96 | $5.30 | 274 369 |
About Aldeyra Therapeutics
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria... ALDX Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.